Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Grotzer

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumorsM A Grotzer, A J Janss, K Fung, et al.
Oncogene|December 8, 2022
Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastomaG Fiaschetti, D Castelletti, S Zoller, et al.
British Journal of Cancer|September 15, 2012
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursA O von Bueren, M D Bacolod, C Hagel, et al.
Oncogene|February 15, 2011
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastomaG Fiaschetti, D Castelletti, S Zoller, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumorsM A Grotzer, A J Janss, K Fung, et al.
Oncogene|December 8, 2022
Correction: Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastomaG Fiaschetti, D Castelletti, S Zoller, et al.
British Journal of Cancer|September 15, 2012
Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumoursA O von Bueren, M D Bacolod, C Hagel, et al.
Oncogene|February 15, 2011
Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastomaG Fiaschetti, D Castelletti, S Zoller, et al.
Pageof 4